MeiraGTx Holdings (FRA:328) Float Percentage Of Total Shares Outstanding: 70.61% (As of Jul. 04, 2026)


FRA:328 MeiraGTx Holdings PLC FRA:328
55 GF Score
Price €12.00
GF Value €20.58
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is MeiraGTx Holdings Float Percentage Of Total Shares Outstanding?

MeiraGTx Holdings FRA:328 +8.11% 55 Float Percentage Of Total Shares Outstanding is 70.61% as of Jul. 04, 2026. GuruFocus rates FRA:328 with a GF Score™ of 55/100 and a GF Value™ of €20.58 (Possible Value Trap). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, MeiraGTx Holdings's float shares is 65.39 Mil. MeiraGTx Holdings's total shares outstanding is 92.61 Mil. MeiraGTx Holdings's float percentage of total shares outstanding is 70.61%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, MeiraGTx Holdings's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, MeiraGTx Holdings's Institutional Ownership is 8.37%.

FRA:328
55GF Score
MeiraGTx Holdings PLC FRA:328
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MeiraGTx Holdings Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

MeiraGTx Holdings's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=65.39/92.61
=70.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 70.61% mean?
MeiraGTx Holdings (FRA:328) has a Float Percentage Of Total Shares Outstanding of 70.61% as of Jul. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on MeiraGTx Holdings and its competitors.
Is MeiraGTx Holdings' Float Percentage Of Total Shares Outstanding too high?
MeiraGTx Holdings' current Float Percentage Of Total Shares Outstanding is 70.61%. Overall, MeiraGTx Holdings has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MeiraGTx Holdings' Float Percentage Of Total Shares Outstanding compare to XNCR and WVE?
MeiraGTx Holdings' Float Percentage Of Total Shares Outstanding of 70.61% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on MeiraGTx Holdings and its competitors. MeiraGTx Holdings's current Float Percentage Of Total Shares Outstanding is 70.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeiraGTx Holdings stock overvalued right now?
Based on GuruFocus' analysis, MeiraGTx Holdings (FRA:328) is currently considered Possible Value Trap. The stock's GF Value™ is €20.58, compared to a current price of €12.00 — trading 41.7% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 70.61%. MeiraGTx Holdings' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For MeiraGTx Holdings (FRA:328), the current Float Percentage Of Total Shares Outstanding is 70.61% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MeiraGTx Holdings (FRA:328) Overvalued in 2026?

Based on GuruFocus' analysis, MeiraGTx Holdings stock appears to be undervalued. The current stock price of €12.00 is trading 41.7% below its estimated GF Value™ of €20.58. GuruFocus considers MeiraGTx Holdings to be Possible Value Trap.

Key valuation signals for FRA:328:

  • Float Percentage Of Total Shares Outstanding: 70.61%
  • GF Value™: €20.58 vs. price of €12.00 (41.7% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the FRA:328 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MeiraGTx Holdings Business Description

Other Exchanges MGTX:USA328:Germany
Address 655 Third Avenue, Suite 1115, New York, NY, USA, 10017
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
55GF Score

Get the complete analysis for FRA:328

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.00
Price
€20.58
GF Value